NEW YORK (AVAFIN) -- A total of 191 block trades were executed today, typically at least 10,000
shares or more represent a single block unit. Block trades help investors understand the
sentiment of large financial institutions. Further trading analysis reveals that
1,668,705 shares were bought and 1,409,181 shares were sold.
The bought/sold ratio for shares of ACADIA Pharmaceuticals is 1.18, representing a
positive net cash flow of $1,556,567 into
the stock.
View all Block Trading Activities
Options traders were busy as well, a total of 4,240 call and 4,358 put contracts were traded
yesterday yielding a 1.03 put/call ratio.
Shares of ACADIA Pharmaceuticals edged up $3.13 (+136.09%) to $5.43. The price of the stock ranged
between a low of $5.06 and $6.54 respectively. The trading volume of 60M is above
the 90 day average volume of 2M shares. The technical momentum Relative Strength Index indicator shows overbought conditions. ACAD is trading above the 50
day moving average. The stock's 52 week low is $0.93 and 52 week high is $6.54. Within the last quarter, the shares have gained 201.67% of their value.
View Best Performing Stocks
ACADIA Pharmaceuticals Inc. is focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders.
